Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

JGP Global Gestao de Recursos Ltda. 13F Holdings -- Portfolio & Top Positions (2026-06-30)

JGP Global Gestao de Recursos Ltda. (CIK 1536562) reported $45.3M across 29 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: XP ($10.7M, 23.60%), SPY ($7.7M, 16.95%), SFTBY ($4.3M, 9.38%), VEON ($3.5M, 7.69%), PROSY ($3.0M, 6.57%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1XPXP INC - CLASS A$10.7M23.60%657,579Added
2SPYSPDR S&P 500 ETF TRUST$7.7M16.95%10,290New
3SFTBYSOFTBANK GROUP CORP-UNSP ADR$4.3M9.38%225,833New
4VEONVEON LTD$3.5M7.69%66,750New
5PROSYPROSUS NV -SPON ADR$3.0M6.57%342,397New
6ATAIATAIBECKLEY INC$2.6M5.81%500,000New
7SATSECHOSTAR CORP-A$2.2M4.84%21,635New
8CKHUYCK HUTCHISON HOLDIN-UNSP ADR$1.5M3.36%179,486New
9ITUBITAU UNIBANCO HLDNG-PREF ADR$1.4M3.02%167,800New
10LLYELI LILLY & CO$1.3M2.91%1,098Trimmed
11ABBVABBVIE INC$722,4581.59%2,871Trimmed
12INCYINCYTE CORP$637,0831.41%5,620Hold
13JNJJOHNSON & JOHNSON$601,4011.33%2,368Added
14UNHUNITEDHEALTH GROUP INC$516,6281.14%1,243New
15ONCBEIGENE LTD-ADR$487,5841.08%1,711Hold
16MRKMERCK & CO. INC.$433,3020.96%3,372New
17STMSTMICROELECTRONICS NV-NY SHS$400,5120.88%5,348New
18NVDANVIDIA CORP$373,5000.82%3,000Added
19VRTXVERTEX PHARMACEUTICALS INC$360,1290.79%725Added
20BMYBRISTOL-MYERS SQUIBB CO$354,5930.78%6,154Trimmed
21RVMDREVOLUTION MEDICINES INC$332,9840.73%1,778New
22GILDGILEAD SCIENCES INC$270,1150.60%2,138Trimmed
23TMOTHERMO FISHER SCIENTIFIC INC$267,7260.59%534Trimmed
24ABTABBOTT LABORATORIES$260,7870.58%2,874Trimmed
25MDGLMADRIGAL PHARMACEUTICALS INC$232,4990.51%433Hold

Source: SEC Form 13F filings · as of 2026-06-30